Search Results

Your search matched 2 results


Patient Advocacy Transparency Act and the Growing Call for Disclosure | Blog

As anticipated, on June 6, 2018, Senator Claire McCaskill (D-Mo.) introduced the Patient Advocacy Transparency Act.


Advancing the Patient Voice in Clinical Trials | Blog

Recently, the FDA issued Collecting Comprehensive and Representative Input, the first of four patient-focused drug development (PFDD) guidance documents.